These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 14616684)

  • 1. Community-acquired pneumonia: causes of treatment failure in patients enrolled in clinical trials.
    Genné D; Kaiser L; Kinge TN; Lew D
    Clin Microbiol Infect; 2003 Sep; 9(9):949-54. PubMed ID: 14616684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotics for community acquired pneumonia in adult outpatients.
    Bjerre LM; Verheij TJ; Kochen MM
    Cochrane Database Syst Rev; 2004; (2):CD002109. PubMed ID: 15106168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Empiric antibiotic coverage of atypical pathogens for community acquired pneumonia in hospitalized adults.
    Robenshtok E; Shefet D; Gafter-Gvili A; Paul M; Vidal L; Leibovici L
    Cochrane Database Syst Rev; 2008 Jan; (1):CD004418. PubMed ID: 18254049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Empiric antibiotic coverage of atypical pathogens for community acquired pneumonia in hospitalized adults.
    Shefet D; Robenshtock E; Paul M; Leibovici L
    Cochrane Database Syst Rev; 2005 Apr; (2):CD004418. PubMed ID: 15846713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in antibiotic therapy for community-acquired pneumonia.
    Viasus D; Garcia-Vidal C; Carratalà J
    Curr Opin Pulm Med; 2013 May; 19(3):209-15. PubMed ID: 23422416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-course vs long-course antibiotic treatment for community-acquired pneumonia: A literature review.
    Møller Gundersen K; Nygaard Jensen J; Bjerrum L; Hansen MP
    Basic Clin Pharmacol Toxicol; 2019 May; 124(5):550-559. PubMed ID: 30694600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-Course vs Long-Course Antibiotic Therapy for Children With Nonsevere Community-Acquired Pneumonia: A Systematic Review and Meta-analysis.
    Li Q; Zhou Q; Florez ID; Mathew JL; Shang L; Zhang G; Tian X; Fu Z; Liu E; Luo Z; Chen Y
    JAMA Pediatr; 2022 Dec; 176(12):1199-1207. PubMed ID: 36374480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftaroline fosamil for community-acquired pneumonia and skin and skin structure infections: a systematic review.
    El Hajj MS; Turgeon RD; Wilby KJ
    Int J Clin Pharm; 2017 Feb; 39(1):26-32. PubMed ID: 28058593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic value of serum procalcitonin in identifying the etiology of non-responding community-acquired pneumonia after initial antibiotic therapy].
    Wang Z; Zhang X; Wu J; Zhang W; Kuang H; Li X; Xuan W; Wang K; Ma L
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Nov; 37(11):824-30. PubMed ID: 25604112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique considerations in the evaluation of antibacterials in clinical trials for pediatric community-acquired pneumonia.
    Bradley JS; McCracken GH
    Clin Infect Dis; 2008 Dec; 47 Suppl 3():S241-8. PubMed ID: 18986297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrolides vs. quinolones for community-acquired pneumonia: meta-analysis of randomized controlled trials.
    Skalsky K; Yahav D; Lador A; Eliakim-Raz N; Leibovici L; Paul M
    Clin Microbiol Infect; 2013 Apr; 19(4):370-8. PubMed ID: 22489673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotics for community acquired pneumonia in children.
    Kabra SK; Lodha R; Pandey RM
    Cochrane Database Syst Rev; 2006 Jul; (3):CD004874. PubMed ID: 16856067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community-acquired pneumonia with risk for drug-resistant pathogens.
    Fleming V; Buck B; Nix N; Kumar P; Southwood R
    South Med J; 2013 Mar; 106(3):209-16. PubMed ID: 23462490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotics for community-acquired pneumonia.
    Dryden M; Hand K; Davey P;
    J Antimicrob Chemother; 2009 Dec; 64(6):1123-5. PubMed ID: 19820250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines to Manage Community-Acquired Pneumonia.
    Wunderink RG
    Clin Chest Med; 2018 Dec; 39(4):723-731. PubMed ID: 30390744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of short-course antibiotic regimens for community-acquired pneumonia: a meta-analysis.
    Li JZ; Winston LG; Moore DH; Bent S
    Am J Med; 2007 Sep; 120(9):783-90. PubMed ID: 17765048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How good is the evidence for the recommended empirical antimicrobial treatment of patients hospitalized because of community-acquired pneumonia? A systematic review.
    Oosterheert JJ; Bonten MJ; Hak E; Schneider MM; Hoepelman IM
    J Antimicrob Chemother; 2003 Oct; 52(4):555-63. PubMed ID: 12972448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review on antibiotic therapy for pneumonia in children between 2 and 59 months of age.
    Lassi ZS; Das JK; Haider SW; Salam RA; Qazi SA; Bhutta ZA
    Arch Dis Child; 2014 Jul; 99(7):687-93. PubMed ID: 24431417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoroquinolone treatment of community-acquired pneumonia: a meta-analysis.
    Salkind AR; Cuddy PG; Foxworth JW
    Ann Pharmacother; 2002 Dec; 36(12):1938-43. PubMed ID: 12452758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the best approach to the nonresponding patient with community-acquired pneumonia?
    Sialer S; Liapikou A; Torres A
    Infect Dis Clin North Am; 2013 Mar; 27(1):189-203. PubMed ID: 23398874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.